PMID- 16034537
OWN - NLM
STAT- MEDLINE
DCOM- 20051207
LR  - 20181113
IS  - 0941-1291 (Print)
IS  - 0941-1291 (Linking)
VI  - 35
IP  - 8
DP  - 2005
TI  - Human leukocyte antigen antibodies for monitoring transplant patients.
PG  - 605-12
AB  - Human leukocyte antigen (HLA) antibody-mediated hyperacute rejection has 
      dramatically decreased since the clinical introduction of crossmatch technology. 
      However, the role of HLA antibody in acute and chronic rejection remains unclear. 
      In this article, we cite publications to show the correlation between HLA 
      antibody and allograft rejection. Potential pathological mechanisms of 
      antibody-mediated rejection are also proposed and the rationale of commonly used 
      HLA antibody detection techniques are introduced. The advantages and 
      disadvantages of these technologies are further discussed in detail. We conclude 
      that owing to the recent availability of improved antibody detection methods, a 
      causal relationship between HLA antibodies and allograft rejection is now 
      considered to exist.
FAU - Cai, Junchao
AU  - Cai J
AD  - Terasaki Foundation Laboratory, 11570 West Olympic Boulevard, Los Angeles, CA, 
      90064, USA.
FAU - Terasaki, Paul I
AU  - Terasaki PI
LA  - eng
PT  - Journal Article
PT  - Review
PL  - Japan
TA  - Surg Today
JT  - Surgery today
JID - 9204360
RN  - 0 (HLA Antigens)
SB  - IM
MH  - Graft Rejection/*immunology
MH  - HLA Antigens/*immunology
MH  - Humans
RF  - 99
EDAT- 2005/07/22 09:00
MHDA- 2005/12/13 09:00
CRDT- 2005/07/22 09:00
PHST- 2004/09/07 00:00 [received]
PHST- 2005/01/18 00:00 [accepted]
PHST- 2005/07/22 09:00 [pubmed]
PHST- 2005/12/13 09:00 [medline]
PHST- 2005/07/22 09:00 [entrez]
AID - 10.1007/s00595-005-3015-6 [doi]
PST - ppublish
SO  - Surg Today. 2005;35(8):605-12. doi: 10.1007/s00595-005-3015-6.